Huawei announces blood sugar risk assessment tool for upcoming Watch 4
Huawei has announced a new blood sugar tracking tool for the upcoming Watch 4. The feature was unveiled in a Weibo post by Huawei’s CEO, Yu Chengdong. It is worth noting that the tool will be available to a limited audience who agree to partake in a joint research project between Huawei and an unnamed third-party medical institution. It also appears that the feature will only be available in China for now, though this has not been confirmed.
The tool will give the wearer of the Huawei Watch 4 an idea of how high their blood sugar level is. A mockup suggests the Hyperglycemia Risk Assessment tool describes your risk level from low to high. The watch could also show you how to improve, for example, by curbing your intake of high-sugar or high-fat foods. However, notes at the bottom of the image indicate that the picture is for reference only and may not accurately represent the final product.
Huawei states that the watch will not be a medical device and that any measurements taken by the wearable should only be used as a guide. A report by Huawei Central implies that the non-invasive wrist-based glucose measurement is determined through a combination of metrics, including heart rate and pulse wave analysis. The Huawei Watch 4 was unveiled earlier this month with health features such as heart rate, SpO2 and skin temperature sensors. The Hyperglycemia detecting tool was not noted in the European release. The new smartwatch will launch on May 18 in China, arriving in Europe in June.
Source(s)
